|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
Lung Cancer Screen 20 Tissue Microarray - LS-SLUCA20
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SLUCA20 |
| Product Name: |
Lung Cancer Screen 20 |
| Description: |
Lung adenocarcinoma with stage/grade and normal/non-neoplastic lung |
| Format: |
FFPE |
| Category: |
Human Tumor and Normal |
| QA/QC: |
H&E reviewed |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Core Diameter: |
1 mm |
| Core Thickness: |
5 µm |
| Cases: |
30 |
| Cores: |
40 |
| Slides Per Set: |
1 |
LS-SLUCA20 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | | A | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | B | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | C | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | D | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendLung (Lng); Lung, Alveolar epithelium (Lng); Lung, Alveolar wall (Lng);
LS-SLUCA20 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Grade |
|---|
| 1 | A1 | Human | M | 66 y | Lung (Lng) | Adenocarcinoma, Papillary | Malignant | T2N0M0 | 1 |
| 1 | A2 | Human | M | 58 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N1M0 | 1 |
| 1 | A3 | Human | M | 61 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N1M0 | 2 |
| 1 | A4 | Human | F | 60 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 |
| 1 | A5 | Human | M | 50 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | 2 |
| 1 | A6 | Human | M | 55 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 |
| 1 | A7 | Human | M | 62 y | Lung (Lng) | Adenocarcinoma, Papillary | Malignant | T2N0M0 | 1 |
| 1 | A8 | Human | M | 60 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 |
| 1 | A9 | Human | M | 70 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 |
| 1 | A10 | Human | M | 70 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | 2 |
| 1 | B1 | Human | M | 70 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | 2 |
| 1 | B2 | Human | M | 65 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 |
| 1 | B3 | Human | M | 67 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 |
| 1 | B4 | Human | F | 42 y | Lung (Lng) | Adenocarcinoma, Papillary | Malignant | T3N1M0 | 2 |
| 1 | B5 | Human | M | 47 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | 2 |
| 1 | B6 | Human | M | 51 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 3 |
| 1 | B7 | Human | M | 59 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N1M0 | 2 |
| 1 | B8 | Human | M | 61 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | 3 |
| 1 | B9 | Human | F | 49 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | 3 |
| 1 | B10 | Human | F | 50 y | Lung, Alveolar epithelium (Lng) | Adenocarcinoma with chronic inflammation and hyperplasia | Malignant | T3N0M0 | |
| 1 | C1 | Human | F | 38 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C2 | Human | F | 38 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C3 | Human | M | 49 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C4 | Human | M | 49 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C5 | Human | M | 55 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C6 | Human | M | 55 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C7 | Human | M | 50 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C8 | Human | M | 50 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C9 | Human | M | 22 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | C10 | Human | M | 22 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D1 | Human | M | 35 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D2 | Human | M | 35 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D3 | Human | M | 47 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D4 | Human | M | 47 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D5 | Human | F | 15 y | Lung, Alveolar wall (Lng) | Normal with fibroplasia | Diseased | | |
| 1 | D6 | Human | F | 15 y | Lung, Alveolar wall (Lng) | Normal with fibroplasia | Diseased | | |
| 1 | D7 | Human | M | 42 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D8 | Human | M | 42 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D9 | Human | M | 47 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | D10 | Human | M | 47 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
